Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Wolpin BM"'
Autor:
Ko AH; Division of Hematology/Oncology, University of California San Francisco, 1825 4th Street, San Francisco, CA, 941158, USA. andrew.ko@ucsf.edu., Coveler AL; Division of Hematology/Oncology, University of Washington Medical Center, Seattle, WA, USA., Schlechter BL; Division of Gastrointestinal Oncology, Dana Farber Cancer Institute, Boston, MA, USA., Bekaii-Saab T; Division of Hematology/Oncology, Mayo Clinic, Scottsdale, AZ, USA., Wolpin BM; Division of Gastrointestinal Oncology, Dana Farber Cancer Institute, Boston, MA, USA., Clark JW; Division of Hematology/Oncology, Massachusetts General Hospital, Boston, MA, USA., Bockorny B; Division of Hematology/Oncology, Beth Israel Deaconess Medical Center, Boston, MA, USA., Bai LY; Division of Hematology and Oncology, Department of Internal Medicine, China Medical University Hospital, Taichung, Taiwan., Lin YC; AltruBio, Inc, San Francisco, CA, USA., Chiang E; AltruBio, Inc, San Francisco, CA, USA., Langecker P; Caidya, Morrisville, NC, USA., Lin SY; AltruBio, Inc, San Francisco, CA, USA.
Publikováno v:
Investigational new drugs [Invest New Drugs] 2024 Apr; Vol. 42 (2), pp. 221-228. Date of Electronic Publication: 2024 Mar 05.
Autor:
Goyal L; Harvard Medical School, Boston, MA, USA.; Massachusetts General Hospital Cancer Center, 55 Fruit Street, 223 Bartlett Hall, Boston, 02114, MA, USA., Chaudhary SP; Harvard Medical School, Boston, MA, USA. Schaudhary1@mgh.harvard.edu.; Massachusetts General Hospital Cancer Center, 55 Fruit Street, 223 Bartlett Hall, Boston, 02114, MA, USA. Schaudhary1@mgh.harvard.edu., Kwak EL; Harvard Medical School, Boston, MA, USA.; Massachusetts General Hospital Cancer Center, 55 Fruit Street, 223 Bartlett Hall, Boston, 02114, MA, USA., Abrams TA; Harvard Medical School, Boston, MA, USA.; Dana Farber Cancer Institute, Boston, MA, USA., Carpenter AN; Massachusetts General Hospital Cancer Center, 55 Fruit Street, 223 Bartlett Hall, Boston, 02114, MA, USA., Wolpin BM; Harvard Medical School, Boston, MA, USA.; Dana Farber Cancer Institute, Boston, MA, USA., Wadlow RC; Virginia Cancer Specialist, Fairfax, VA, USA., Allen JN; Harvard Medical School, Boston, MA, USA.; Massachusetts General Hospital Cancer Center, 55 Fruit Street, 223 Bartlett Hall, Boston, 02114, MA, USA., Heist R; Harvard Medical School, Boston, MA, USA.; Massachusetts General Hospital Cancer Center, 55 Fruit Street, 223 Bartlett Hall, Boston, 02114, MA, USA., McCleary NJ; Harvard Medical School, Boston, MA, USA.; Dana Farber Cancer Institute, Boston, MA, USA., Chan JA; Harvard Medical School, Boston, MA, USA.; Dana Farber Cancer Institute, Boston, MA, USA., Goessling W; Harvard Medical School, Boston, MA, USA.; Dana Farber Cancer Institute, Boston, MA, USA., Schrag D; Harvard Medical School, Boston, MA, USA.; Dana Farber Cancer Institute, Boston, MA, USA., Ng K; Harvard Medical School, Boston, MA, USA.; Dana Farber Cancer Institute, Boston, MA, USA., Enzinger PC; Harvard Medical School, Boston, MA, USA.; Dana Farber Cancer Institute, Boston, MA, USA., Ryan DP; Harvard Medical School, Boston, MA, USA.; Massachusetts General Hospital Cancer Center, 55 Fruit Street, 223 Bartlett Hall, Boston, 02114, MA, USA., Clark JW; Harvard Medical School, Boston, MA, USA.; Massachusetts General Hospital Cancer Center, 55 Fruit Street, 223 Bartlett Hall, Boston, 02114, MA, USA.
Publikováno v:
Investigational new drugs [Invest New Drugs] 2020 Oct; Vol. 38 (5), pp. 1533-1539. Date of Electronic Publication: 2020 Jan 02.
Autor:
Noel M; Department of Medicine, Division of Hematology/Oncology, University of Rochester Medical Center School of Medicine & Dentistry, Rochester, NY, USA., O'Reilly EM; Department of Medicine, Memorial Sloan Kettering Cancer Center, Weill Cornell Medical College, New York, NY, USA., Wolpin BM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Ryan DP; MGH Cancer Center, Division of Hematogy-Oncology, Massachusetts General Hospital, Boston, MA, USA., Bullock AJ; Division of Hematology/Oncology, Beth Israel Deaconess Medical Center, Boston, MA, USA., Britten CD; Division of Hematology/Oncology, Medical University of South Carolina, Charleston, SC, USA., Linehan DC; Department of Surgery, University of Rochester Medical Center School of Medicine & Dentistry, Rochester, NY, USA., Belt BA; Department of Surgery, University of Rochester, Rochester, NY, USA., Gamelin EC; Early Oncology Development and Clinical Research, Pfizer Inc, 219 East 42nd Street, New York, NY, 10017, USA., Ganguly B; Early Oncology Development and Clinical Research, Pfizer Inc, 219 East 42nd Street, New York, NY, 10017, USA.; Lyell Immunopharma Inc, Palo Alto, CA, USA., Yin D; Early Oncology Development and Clinical Research, Pfizer Inc, 219 East 42nd Street, New York, NY, 10017, USA., Joh T; Early Oncology Development and Clinical Research, Pfizer Inc, 219 East 42nd Street, New York, NY, 10017, USA., Jacobs IA; Early Oncology Development and Clinical Research, Pfizer Inc, 219 East 42nd Street, New York, NY, 10017, USA. ira.jacobs@pfizer.com., Taylor CT; Early Oncology Development and Clinical Research, Pfizer Inc, 219 East 42nd Street, New York, NY, 10017, USA., Lowery MA; Trinity St James's Cancer Institute, Trinity College Dublin, Dublin, Ireland.
Publikováno v:
Investigational new drugs [Invest New Drugs] 2020 Jun; Vol. 38 (3), pp. 800-811. Date of Electronic Publication: 2019 Jul 12.
Neoadjuvant Therapy is Associated with Improved Survival in Borderline-Resectable Pancreatic Cancer.
Autor:
Chawla A; Division of Surgical Oncology, Department of Surgery, Northwestern Medicine Regional Medical Group, Northwestern University Feinberg School of Medicine, Chicago, IL, USA., Molina G; Division of Surgical Oncology, Department of Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA., Pak LM; Division of Surgical Oncology, Department of Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA., Rosenthal M; Dana Farber/Brigham and Women Cancer Center, Boston, MA, USA.; Department of Radiology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA., Mancias JD; Dana Farber/Brigham and Women Cancer Center, Boston, MA, USA.; Department of Radiation Oncology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA., Clancy TE; Division of Surgical Oncology, Department of Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.; Dana Farber/Brigham and Women Cancer Center, Boston, MA, USA., Wolpin BM; Dana Farber/Brigham and Women Cancer Center, Boston, MA, USA.; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA., Wang J; Division of Surgical Oncology, Department of Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. jwang39@bwh.harvard.edu.; Dana Farber/Brigham and Women Cancer Center, Boston, MA, USA. jwang39@bwh.harvard.edu.
Publikováno v:
Annals of surgical oncology [Ann Surg Oncol] 2020 Apr; Vol. 27 (4), pp. 1191-1200. Date of Electronic Publication: 2019 Dec 04.
Autor:
Goyal L; Massachusetts General Hospital Cancer Center, 55 Fruit Street, LH/PB 220, Boston, MA, 02114, USA, lgoyal@partners.org., Wadlow RC, Blaszkowsky LS, Wolpin BM, Abrams TA, McCleary NJ, Sheehan S, Sundaram E, Karol MD, Chen J, Zhu AX
Publikováno v:
Investigational new drugs [Invest New Drugs] 2015 Feb; Vol. 33 (1), pp. 128-37. Date of Electronic Publication: 2014 Sep 24.
Autor:
Rubinson DA; Department of Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA, 02215, USA., Hochster HS, Ryan DP, Wolpin BM, McCleary NJ, Abrams TA, Chan JA, Iqbal S, Lenz HJ, Lim D, Rose J, Bekaii-Saab T, Chen HX, Fuchs CS, Ng K
Publikováno v:
Investigational new drugs [Invest New Drugs] 2014 Feb; Vol. 32 (1), pp. 113-22. Date of Electronic Publication: 2013 Apr 09.
Autor:
Faris JE; Department of Medical Oncology, Massachusetts General Hospital Cancer Center, POB 221, Boston, MA 02114, USA., Arnott J, Zheng H, Ryan DP, Abrams TA, Blaszkowsky LS, Clark JW, Enzinger PC, Hezel AF, Ng K, Wolpin BM, Kwak EL
Publikováno v:
Investigational new drugs [Invest New Drugs] 2012 Aug; Vol. 30 (4), pp. 1614-20. Date of Electronic Publication: 2011 Jul 29.